Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma

Cancer Investigation
Hüseyin AbaliNurullah Zengin

Abstract

High dose chemotherapy with autologous stem cell transplantation is currently the treatment of choice for relapsed or refractory lymphoma patients. However, its applicability is mostly restricted to patients responding to salvage chemotherapy. Optimal salvage regimen for these patients is unclear. In this study, our aim was to compare the efficacy and toxicity profiles of DHAP (cytosine arabinoside, cisplatin and dexamethasone) and ICE (ifosfamide, carboplatin and etoposide) regimens in the salvage treatment of relapsed and refractory lymphoma. In this retrospective analysis, 53 patients with primary refractory or relapsed Hodgkin's disease (HD) (n = 13) or non-Hodgkin lymphoma (NHL) (n = 40) who received ICE or DHAP salvage regimen were included. Of 53 patients, 21 (39,6%) were female and the median age was 43 years. A total of 73 courses of ICE and 59 courses of DHAP were administered. Response could be evaluated in 49 patients (36 NHL and 13 HD). Of 49 patients, 11 (22.5%) achieved complete remission (CR) and 17 (35%) achieved partial remission (PR), leading to an overall response rate (ORR: CR + PR) of 57.5%. In the evaluable ICE group (n = 22) rates of CR, PR, and ORR were 27%, 41% and 68% and in the DHAP group (n = 27) ra...Continue Reading

References

Jan 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SantoroF Crippa
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S VelasquezF Cabanillas
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C H MoskowitzA D Zelenetz
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M VoseUNKNOWN Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Oct 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A JostingUNKNOWN Participating Centers
Jun 13, 2003·The New England Journal of Medicine·Volker DiehlUNKNOWN German Hodgkin's Lymphoma Study Group
Jun 13, 2003·The New England Journal of Medicine·Berthe M P AlemanUNKNOWN European Organization for Research and Treatment of Cancer Lymphoma Group
Aug 22, 2003·British Journal of Haematology·Vincent T DeVita
Sep 17, 2004·CA: a Cancer Journal for Clinicians·Bruce D Cheson
Mar 25, 2005·The New England Journal of Medicine·Félix ReyesUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA)

❮ Previous
Next ❯

Citations

Apr 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Assia L AngelovaZahari Raykov
Nov 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Fernández de LarreaE Carreras
Oct 23, 2010·Expert Opinion on Drug Delivery·Bhupender S Chhikara, Keykavous Parang
Jan 22, 2015·Electrolyte & Blood Pressure : E & BP·Gi-Su OhHong-Seob So
Jan 9, 2019·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Hailey HillStephen Park
Oct 26, 2013·Annals of Hematology·Eliza A HawkesIan Chau
Sep 30, 2019·Journal of Cancer Research and Clinical Oncology·Frank KroschinskyMathias Hänel
Jun 6, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Richard T HoppeNdiya Ogba
May 11, 2017·Current Hematologic Malignancy Reports·Niloufer Khan, Alison J Moskowitz
Dec 2, 2014·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Mojtaba GhadianyAbbas Haji Fathali
Aug 23, 2021·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Ahmet SariciMustafa Ozgul

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.